Literature DB >> 1200025

Oral polio vaccination of children in the tropics. II. Antibody response in relation to vaccine virus infection.

T J John.   

Abstract

Poliovirus antibody response rates following the administration of trivalent oral polio vaccine (OPV) have been poor in several developing countries. In an attempt to determine if poor seroresponse is due to poor rates of vaccine virus "take" or due to poor serum antibody response to intestinal virus infection, both vaccine virus take and serum antibody response were determined in a group of children given two doses of OPV. In the large majority of seronegative children there was good correlation between the absence or presence of vaccine virus excretion and negative or positive seroconversion, thus showing that the poor seroconversion rates were mainly due to poor rates of vaccine virus take. However, as in several studies from developed countries showing good seroconversion rates, a few instances of antibody response in the absence of detectable virus excretion and fewer instances of virus excretion without detectable antibody response were also found.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1200025     DOI: 10.1093/oxfordjournals.aje.a112180

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  9 in total

1.  Antibody response of infants in tropics to five doses of oral polio vaccine.

Authors:  T J John
Journal:  Br Med J       Date:  1976-04-03

Review 2.  The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age.

Authors:  N Halsey; A Galazka
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

3.  Pediatric small intestine bacterial overgrowth in low-income countries.

Authors:  Jeffrey R Donowitz; William A Petri
Journal:  Trends Mol Med       Date:  2014-11-15       Impact factor: 11.951

Review 4.  Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine.

Authors:  Myron M Levine
Journal:  BMC Biol       Date:  2010-10-04       Impact factor: 7.431

5.  Efficacy of inactivated poliovirus vaccine in India.

Authors:  R Krishnan; M Jadhav; T J John
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

6.  Oral polio vaccine response in breast fed infants with malnutrition and diarrhea.

Authors:  Rashidul Haque; Cynthia Snider; Yue Liu; Jennie Z Ma; Lei Liu; Uma Nayak; Josyf C Mychaleckyj; Poonum Korpe; Dinesh Mondal; Mamun Kabir; Masud Alam; Mark Pallansch; M Steven Oberste; William Weldon; Beth D Kirkpatrick; William A Petri
Journal:  Vaccine       Date:  2013-12-02       Impact factor: 3.641

7.  Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future.

Authors:  Manish Patel; Stephen Cochi
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

8.  Relationship Between Helicobacter pylori IgG Seroprevalence and the Immune Response to Poliovirus Vaccine Among School-Age Children From a Population With Near-Universal Immunity Level.

Authors:  Layaly Badran Abu Zher; Merav Weil; Eias Kassem; Nael Elias; Myron M Levine; Khitam Muhsen
Journal:  Front Med (Lausanne)       Date:  2022-01-20

Review 9.  Mucosal immunity to poliovirus.

Authors:  Ruth I Connor; Elizabeth B Brickley; Wendy F Wieland-Alter; Margaret E Ackerman; Joshua A Weiner; John F Modlin; Ananda S Bandyopadhyay; Peter F Wright
Journal:  Mucosal Immunol       Date:  2021-07-08       Impact factor: 7.313

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.